Fig. 2From: Integrative stemness characteristics associated with prognosis and the immune microenvironment in lung adenocarcinomaEvaluation of the clinical significance and prognosis of mRNAsi. (A) The mRNAsi value corresponding to LUAD samples and normal samples. (B) Survival analysis of low and high mRNAsi groups. Difference in the pathological T (C) and pathological stage (D) between the low and high mRNAsi groupsBack to article page